What it does
Rhumagel is a medication used for treating joint pain and inflammation.
Commonly used for: joint pain, arthritis
Read more in plain English ↓Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.
Ask about this medicine
Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.
Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.
Sourcing - Kenya onlyRegistration & product details
Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:07:32 · updated 2026-10-22 03:40:00
About this medicine
Rhumagel is a medication used for treating joint pain and inflammation.
What it treats
- joint pain
- arthritis
How it works
Rhumagel works by reducing inflammation and relieving pain in the joints.
Who it's for
This medication is suitable for adults experiencing joint discomfort or conditions like arthritis.
AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.
Clinical monograph: rhumagel
Rhumagel is a topical non-steroidal anti-inflammatory drug (NSAID) used primarily for the relief of pain and inflammation associated with musculoskeletal disorders, such as arthritis and soft tissue injuries. It is applied locally to the affected area, providing targeted relief with minimal systemic absorption. Rhumagel contains ingredients that help to alleviate pain through its anti-inflammatory properties.
Indications
- Osteoarthritis
- Rheumatoid arthritis
- Acute soft tissue injuries
- Musculoskeletal pain
- Tendonitis
Dosage
Children: Refer to the BNF for Children for appropriate dosing guidelines.
Adults: Refer to product-specific guidelines for dosage instructions, typically applied 3-4 times daily to the affected area.
Mechanism of action
Rhumagel works by inhibiting the cyclooxygenase (COX) enzymes, which are responsible for the conversion of arachidonic acid to prostaglandins, mediators of inflammation and pain. By blocking these enzymes, Rhumagel reduces the synthesis of prostaglandins, thereby decreasing inflammation and pain at the site of application.
Pharmacodynamics
The pharmacodynamic effects of Rhumagel manifest as a reduction in pain and swelling in the affected tissues. The localized application minimizes systemic side effects, making it suitable for patients who may be sensitive to oral NSAIDs. The onset of action is typically rapid, providing quick relief to patients experiencing acute pain.
Pharmacokinetics
When applied topically, Rhumagel demonstrates low systemic absorption, which limits its effects on the entire body and reduces the risk of systemic side effects. The drug is primarily metabolized in the liver, and its metabolites are excreted via the kidneys. The pharmacokinetics may vary based on the integrity of the skin barrier and the area of application.
Adverse effects
- Gastrointestinal disturbances
- Nausea
- Diarrhea
- Abdominal pain
Precautions
- Use with caution in patients with renal impairment
- Monitor for gastrointestinal symptoms
- Consider potential interactions with other medications
Pregnancy
There are no adequate and well-controlled studies in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.
Breast-feeding
It is not known whether this drug is excreted in human milk. Caution should be exercised when administering to nursing women.
Storage
Store at room temperature, away from moisture and light. Keep out of reach of children.
Formulations
- Oral gel
- Topical gel
AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.